Facebook
Twitter
LinkedIn
ForwardThe ARIA Toolkit: An Interdisciplinary Curriculum to Optimize Team-Based Management of Amyloid-Related Imaging Abnormalities in Alzheimer’s Disease
Due to the unique educational design of this course, the content must be viewed and completed on the ReachMD platform.
Program Description
The introduction of disease modifying amyloid targeting therapies for Alzheimer’s disease is creating a paradigm shift in the treatment of patients with this condition. But the potential for ARIA prompts several unique considerations over the course of therapy. This curriculum is designed to outline critical roles and best practices in ARIA identification and management across disciplines to prepare you to navigate real-world clinical scenarios.
Target Audience
Mastering ARIA Management: Charting the Path in a Virtual Clinic
An Overview of ARIA: A Multidisciplinary Crash Course for Baseline Clinical Needs
This activity is intended for AD specialists (neurologists, geriatric psychiatrists, geriatricians), radiologists, primary care clinicians, emergency medicine clinicians, nurses, physician associates and other healthcare professionals across these specialties involved in AD care to understand the definition, presentations, implications, and strategic solutions for ARIA as outlined by both individual and collaborative roles.
TIME OUT: A Case-Based Deep Dive into the Challenges of ARIA Management
This activity is intended for AD specialists (neurologists, geriatric psychiatrists, geriatricians), radiologists, emergency medicine clinicians, nurses, physician associates, and other healthcare professionals across these specialties involved in AD care to understand the definition, presentations, implications, and strategic solutions for ARIA as outlined by both individual and collaborative roles.
Learning Objectives
Upon completion of the educational activity, participants should be able to:
Mastering ARIA Management: Charting the Path in a Virtual Clinic
- Recognize symptoms of amyloid-related imaging abnormalities (ARIA) and determine appropriate next steps based on care setting and current recommendations
- Identify both proactive and reactive management strategies that have been employed for individual presentations of ARIA to maximize patient safety while minimizing therapeutic disruption
An Overview of ARIA: A Multidisciplinary Crash Course for Baseline Clinical Needs
- Outline optimal monitoring strategies for ARIA in all patients prescribed anti-Aβ mAbs, and any variations based on individual risk factors, to ensure ARIA is identified in a timely manner
- Recognize possible symptoms of ARIA and determine appropriate next steps based on care setting and current recommendations
- Identify vital elements of interdisciplinary communication and patient counseling regarding ARIA diagnosis and management to ensure safe, comprehensive, and consistent care in patients prescribed anti-Aβ mAbs
TIME OUT: A Case-Based Deep Dive into the Challenges of ARIA Management
- Recognize possible symptoms and differential diagnoses of ARIA and determine appropriate next steps based on care setting and current recommendations
- Recognize and differentiate key radiographic features of ARIA (e.g., type, severity) to accurately interpret imaging findings and properly diagnose ARIA
- Identify both proactive and reactive management strategies that have been employed for individual presentations of ARIA, to maximize patient safety while minimizing therapeutic disruption
James R. Bateman, MD, MPHWake Forest University School of Medicine
Winston-Salem, NC
B. Joy Snider, MD, PhDKnight Alzheimer Disease Research Center at Washington University School of Medicine
Saint Louis, MO
Danya Khoujah, MBBSAdventHealth, Tampa, FL Volunteer Adjunct Assistant Professor,
Department of Emergency Medicine
University of Maryland School of Medicine
Chuck Vega, MDUC Irvine Department of Family Medicine
Director, UCI Program in Medical Education for the Latino Community
Assistant Dean for Culture and Community Education
UC Irvine School of Medicine
Jerome A. Barakos, MDCalifornia Pacific Medical Center, Sutter Health
San Francisco, CA
This activity is jointly provided by Medical Education Resources (MER) and Efficient LLC.
Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by Medical Education Resources (MER) and Efficient LLC. MER is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Designation Statement
Mastering ARIA Management: Charting the Path in a Virtual Clinic
Medical Education Resources has been authorized by the American Academy of Physician Associates (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 0.25 AAPA Category 1 CME Credit. Physician Associates should only claim credit commensurate with the extent of their participation.
An Overview of ARIA: A Multidisciplinary Crash Course for Baseline Clinical Needs
Medical Education Resources has been authorized by the American Academy of Physician Associates (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 0.5 AAPA Category 1 CME Credit. Physician Associates should only claim credit commensurate with the extent of their participation.
TIME OUT: A Case-Based Deep Dive into the Challenges of ARIA Management
Medical Education Resources has been authorized by the American Academy of Physician Associates (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 0.75 AAPA Category 1 CME Credit. Physician Associates should only claim credit commensurate with the extent of their participation.
Staff Disclosures
Efficient LLC and Medical Education Resources' planners and managers have no financial relationships to disclose.
Faculty Disclosures
Dr. Bateman reported the following relationships:
- Grants/Research Support: Alzheimer’s Association; Dementia Alliance of North Carolina
- Consulting Fees: Medscape, NovoNordisk
Dr. Barakos has no relevant financial relationships
Dr. Khoujah has no relevant financial relationships
Dr. Snider reported the following relationships:
- Grants/Research Support: Biogen, Inc., Eisai, Johnson & Johnson Services, Inc., Roche
- Consulting Fees: Eisai, Roche
Dr. Vega has no relevant financial relationships.
Disclosure of All Financial Relationships
Medical Education Resources ensures balance, independence, objectivity, and scientific rigor in all our educational activities. In accordance with this policy, MER identifies all financial relationships with its instructors, content managers, and other individuals who are in a position to control the content of an activity. Reported financial relationships are mitigated by MER to ensure that all scientific research referred to, reported, or used in a CE activity conforms to the generally accepted standards of experimental design, data collection, and analysis. MER is committed to providing learners with high-quality CE activities that promote improvements or quality in health care and not the business interest of an ineligible company.
All relevant conflicts of interest have been mitigated prior to the start of the activity.
Efficient LLC and Medical Education Resources' planners and managers have no financial relationships to disclose.
Disclaimer
The content and views presented in this educational activity are those of the authors and do not necessarily reflect those of Medical Education Resources, Efficient LLC, and/or Lilly. The authors have disclosed if there is any discussion of published and/or investigational uses of agents that are not indicated by the FDA in their presentations. Before prescribing any medicine, primary references and full prescribing information should be consulted. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. The information presented in this activity is not meant to serve as a guideline for patient management.
Commercial Support
This activity is supported by educational grants from Lilly.
Method of Participation
There are no fees for participating in and receiving credit for this activity. During the period December 20, 2024 through December 20, 2025, participants must 1) read the learning objectives and faculty disclosures, 2) complete the pre-activity assessment, 3) study the educational activity, 4) complete the posttest by recording the best answer to each question, and 5) complete the evaluation form.
Media
Internet